SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-026848
Filing Date
2018-11-05
Accepted
2018-11-05 16:16:46
Documents
48
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kura-10q_20180930.htm 10-Q 1642108
2 EX-10.2 kura-ex102_12.htm EX-10.2 83434
3 EX-10.3 kura-ex103_516.htm EX-10.3 371041
4 EX-31.1 kura-ex311_8.htm EX-31.1 17454
5 EX-31.2 kura-ex312_13.htm EX-31.2 17241
6 EX-32.1 kura-ex321_7.htm EX-32.1 9675
7 GRAPHIC g3vn4zqw3x3m000001.jpg GRAPHIC 7049
  Complete submission text file 0001564590-18-026848.txt   5731071

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT kura-20180930.xml EX-101.INS 1262286
9 XBRL TAXONOMY EXTENSION SCHEMA kura-20180930.xsd EX-101.SCH 34781
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kura-20180930_cal.xml EX-101.CAL 33909
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kura-20180930_def.xml EX-101.DEF 92083
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE kura-20180930_lab.xml EX-101.LAB 241392
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kura-20180930_pre.xml EX-101.PRE 171758
Mailing Address 3033 SCIENCE PARK ROAD, SUITE 220 SAN DIEGO CA 92121
Business Address 3033 SCIENCE PARK ROAD, SUITE 220 SAN DIEGO CA 92121 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37620 | Film No.: 181160115
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences